PRE-LAUNCH WHITE PAPER:
Six HFE variants. One well.
Data in under 8 hours
Confident HFE variant detection. No reruns and no waste.
Hereditary hemochromatosis (HHC) affects 1 in 200 people of Northern European descent, yet it remains under-tested in research.
Most research workflows test only the most common HFE variants and miss emerging variants relevant to diverse and aging populations.
In 2025, leading research guidance continues to recommend testing for C282Y, H63D and S65C. Growing evidence supports expanding coverage to include additional, less common variants for more complete population studies.
This HFE Genotyping Panel (RUO) delivers all guideline-recommended variants plus three emerging targets in a single-well workflow. It helps labs reduce reruns, avoid ambiguous calls, and scale from 1 to more than 1,000 samples per day without complex bioinformatics.
This pre-launch whitepaper will allow you to:
- See the complete list of six key HFE variants, including the three most widely recommended plus emerging targets that support research in diverse populations.
- Understand the workflow before you invest: Get a clear explanation of the multiplex PCR and MassARRAY® System process using familiar iPLEX® chemistry.
- Access trusted reference materials: Learn which CDC-characterized DNA samples and commercially available controls can support your panel evaluation and validation.
The follow-up technical white paper will show how the panel performs in real-world labs, giving early adopters the insight they need to move confidently.
By completing the form you will also get:
- Early access to the full technical white paper
- Forthcoming real-world performance insights
Download now and reserve early access.
Download Now
Complete the form to receive this exclusive white paper.